Sponsor: Alliance for Clinical Trials in Oncology
Sponsor Study ID: A042001
Study Title: A Randomized Phase II Study Comparing Inotuzumab plus Chemotherapy versus Standard Chemotherapy in Older Adults with Philadelphia Chromosome Negative B Cell Acute Lymphoblastic Leukemia (ALL)
CTO #: 103882
NCT Number: NCT05303792
Phase: II
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Lymphoid Leukemia
Study Objectives: To compare undetectable MRD event-free survival (EFS) rate of the experimental arm (A) to standard arm (B) with EFS defined as time from randomization to occurrence of an event.